The agreement provides ROCA with the rights to sell in Peru, and includes minimum purchase requirements, said the company.

The SonaStar is used by Neuro and General Surgeons for removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.

The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the danger associated with rotary sharps, said the company.

The SonicOne is an ultrasonic wound care system that offers tissue specific debridement and cleansing for removal of devitalized tissue and fibrin deposits, while sparing viable cellular structures.

Michael McManus, president and chief executive officer of Misonix, said: “Misonix is pleased with the addition of ROCA to our expanding roster of Latin American specialty distributors. ROCA’s reputation as a high-profile distributor of advanced medical equipment in Peru is well known to us.

“Their commitment to quality and service, as well as their success in introducing high tech medical devices, was appealing to Misonix. We are particularly pleased that they will be selling three of our key products through their well established distribution network.”